ワシントンにおける心不全の臨床試験
ワシントン内の拠点で、心不全に関する26件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
被験者募集中
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Virginia Mason Medical Center, Seattle
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06424288A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Redmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Providence Advanced Heart Disease and Transplant, Spokane
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/24更新 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Pulse Heart Institute, Puyallup
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/15更新 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Spokane, WA Investigative Site 10123, Spokane
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06008197A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 132, Seattle
被験者募集中第2相
30歳〜84歳 · 全性別 · 2026/08/31更新 · NCT07795814Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
被験者募集中第2/3相
29 Days – 17 Years · 全性別 · 2026/08/28更新 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/08/27更新 · NCT06793371Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Olympia
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/20更新 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Virginia Mason Medical Center, Seattle
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Seattle
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/08/19更新 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Swedish Medical Center_Seattle, Seattle
- CHI Franciscan Research Center, Tacoma
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Seattle Children's Hospital, Seattle
被験者募集中第2相
0歳〜16歳 · 全性別 · 2026/08/10更新 · NCT06080074Assessment of CCM in HF With Higher Ejection Fraction
- Swedish Medical Center, Seattle
- Peace Health, Vancouver
被験者募集中
18歳以上 · 全性別 · 2026/08/06更新 · NCT05064709PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487Repurposing Valsartan May Protect Against Pulmonary Hypertension
- University of Washington Medical Center, Seattle
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/05/04更新 · NCT06053580CCM OPEN HF Registry
- PeaceHealth Southwest Medical Center, Vancouver
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/23更新 · NCT07112924Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- University of Washington Medical Center, Seattle
被験者募集中
18歳以上 · 全性別 · 2026/03/18更新 · NCT06895070Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
- University of Washington, Seattle
被験者募集中
40歳以上 · 全性別 · 2026/03/16更新 · NCT07105007Left vs Left Randomized Clinical Trial
- University of Washington, Seattle
被験者募集中
18歳以上 · 全性別 · 2025/10/02更新 · NCT05650658Cardiogenic Shock Working Group Registry
- University of Washington Medical Center, Seattle
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/06更新 · NCT04682483Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- University of Washington Medicine, Seattle
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2024/03/26更新 · NCT04703842Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
- University of Washington Medical Center, Seattle
被験者募集中
18歳以上 · 全性別 · 2021/02/23更新 · NCT02537769ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。